Abbott Laboratories Q2 FY25: where the revenue came from and where it went
The whole income statement of Abbott Laboratories for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Apr 1 – Jun 30, 2025
- Reported
- Jul 30, 2025
Revenue$11.14B
+7% year over year
Gross profit$6.29B
56% margin
Operating profit$2.05B
18% margin
Net profit$1.78B
16% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 11.14 | 100% | +7% |
| Medical devices | 5.37 | 48% | +13% |
| Nutritional products | 2.21 | 20% | +3% |
| Diagnostic products | 2.17 | 20% | −1% |
| Established pharmaceutical | 1.38 | 12% | +7% |
| Cost of revenue | −4.85 | 44% | |
| Gross profit | 6.29 | 56% margin | +1pp |
| R&D | −0.73 | 6% | +0pp |
| SG&A | −3.09 | 28% | −1pp |
| Other | −0.42 | 4% | +0pp |
| Operating profit | 2.05 | 18% margin | +2pp |
| Other income, net | 0.10 | ||
| Tax | −0.37 | ||
| Net profit | 1.78 | 16% margin | +3pp |
378 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest